You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美單日新增12.54萬宗新冠確診 輝瑞擬爭取準成年人接種第三劑復必泰
阿思達克 11-09 16:00
美國新冠疫情持續。據美國約翰霍普金斯大學統計,美國截至西岸時間午夜(本港時間下午4時)累計確診46,613,210宗,單日新增125,402宗。累計新冠死亡個案755,643宗,單日新增1,213宗。 《華盛頓郵報》引述消息報道,美國輝瑞(PFE.US)及德國BioNTech(BNTX.US)最快周內尋求美國當局批準,讓所有成年人接種第三劑「復必泰」。消息指美國食品及樂物管理局(FDA)料將批準有關要求,令全美所有成年人合資格接種第三劑疫苗。 另外,在洛杉磯市政廳外有千計示威者反對當地最新疫苗接種規定,該規定要求進入商業地方及大部分政府建築物人士證明已接種疫苗或新冠檢測陰性。違反有關規定的地點將於本月29日起面臨罰款。紐約市市長白思豪表示,該市政府93%僱員已接種新冠疫苗,該市與4個工會早前協議,允許僱員以醫療或宗教理由不接種疫苗,但同時確認市政府有權實施強制接種規定。 下表爲美國過去八日每日新冠疫情統計: 日期│累計確診│單日新增確診│累計死亡│單日新增死亡 11月 8日(一)│46,613,210宗│+125,402宗│755,643宗│+1,213宗 11月 7日(日)│46,487,808宗│+ 26,058宗│754,430宗│+ 151宗 11月 6日(六)│46,461,750宗│+ 25,685宗│754,279宗│+ 349宗 11月 5日(五)│46,436,065宗│+101,183宗│753,930宗│+2,375宗 11月 4日(四)│46,334,882宗│+ 82,333宗│751,555宗│+1,129宗 11月 3日(三)│46,252,549宗│+ 83,537宗│750,426宗│+1,908宗 11月 2日(二)│46,169,012宗│+ 77,088宗│748,518宗│+1,485宗 11月 1日(一)│46,091,924宗│+121,121宗│747,033宗│+1,201宗
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account